Free Trial
LON:CLIN

Clinigen Group (CLIN) Share Price, News & Analysis

Clinigen Group logo

About Clinigen Group Stock (LON:CLIN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
925
925
52-Week Range
N/A
Volume
539,375 shs
Average Volume
1.83 million shs
Market Capitalization
£1.23 billion
P/E Ratio
64.69
Dividend Yield
0.82%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clinigen Group and its competitors with MarketBeat's FREE daily newsletter.

CLIN Stock News Headlines

Clinigence Holdings (NUTX) Receives a Buy from Maxim Group
Evotec Shares Jump After Triton Acquires Stake
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
Triton Weighs Takeover Deal for Drug Developer Evotec
See More Headlines

CLIN Stock Analysis - Frequently Asked Questions

Clinigen Group plc (LON:CLIN) released its quarterly earnings data on Thursday, September, 17th. The company reported $65.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $63.50 by $2.10.

Shares of CLIN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Clinigen Group investors own include Comerica (CMA), Honda Motor (HMC), Albemarle (ALB), Advanced Accelerator Applications (AAAP), First Hawaiian (FHB), GE Aerospace (GE) and Landec (LNDC).

Company Calendar

Last Earnings
9/17/2020
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Delivery
Sub-Industry
Trading
Current Symbol
LON:CLIN
CIK
N/A
Fax
N/A
Employees
1,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
64.69
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
90.77
Current Ratio
1.89
Quick Ratio
1.48

Sales & Book Value

Annual Sales
£565.60 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
10.48
Book Value
GBX 341.90 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
133,367,000
Free Float
N/A
Market Cap
£1.23 billion
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (LON:CLIN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners